Champions Oncology, Inc.
CSBR
$7.63
$0.222.97%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 164.61% | 166.07% | 93.79% | 55.20% | -36.38% |
| Total Depreciation and Amortization | -12.16% | -7.14% | 0.85% | 10.71% | 15.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.17% | -34.82% | -22.92% | -15.07% | 9.83% |
| Change in Net Operating Assets | 83.76% | -1,923.60% | -425.38% | -226.20% | -190.10% |
| Cash from Operations | 220.35% | 74.11% | -7.38% | -1,142.61% | -254.51% |
| Capital Expenditure | 53.47% | 91.68% | 91.91% | 93.97% | 70.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 53.47% | 91.68% | 91.91% | 93.97% | 70.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.74% | -38.89% | -97.30% | -- | -- |
| Issuance of Common Stock | 26.48% | 25.00% | 9.92% | 145.92% | 194.19% |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 95.27% | -745.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 132.26% | 129.20% | 124.67% | 104.49% | -4,890.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 195.56% | 82.36% | 48.07% | 38.01% | -775.07% |